Search
-
Antiviral activity of S/GSK1349572, the only once-daily, unboosted integrase inhibitor in clinical development, evaluated in phase 2 study
Media
GSK announced results from Phase 2a study evaluating antiviral activity of INI, S/GSK1349572, results presented at IAS Conference.
https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1349572-the-only-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-2-study/
First published: 20 July 2009
-
Antiviral Activity of S/GSK1265744, a Once-Daily, Unboosted Integrase Inhibitor in Clinical Development, Evaluated in Phase 1-2a Study in Healthy and HIV-Infected Subjects
Media
GSK announced results from Phase 1-2a study evaluating PK, safety and activity of its INI S/GSK1265744 in healthy HIV-infected patients.
https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1265744-a-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-1-2a-study-in-healthy-and-hiv-infected-subjects/
First published: 13 September 2009
-
Press Release GSK Receives US FDA Fast Track Designation For Bepirovirsen
Media
https://www.gsk.com/media/10957/press-release-gsk-receives-us-fda-fast-track-designation-for-bepirovirsen.pdf
First published: 12 February 2024
-
GSK Receives US FDA Fast Track Designation For Bepirovirsen Press Release
Media
https://www.gsk.com/media/10959/gsk-receives-us-fda-fast-track-designation-for-bepirovirsen-press-release.pdf
First published: 12 February 2024
-
Press Release Agreement To Obtain Exclusive License For JNJ 3989 31 Oct 2023
Media
https://www.gsk.com/media/10660/press-release-agreement-to-obtain-exclusive-license-for-jnj-3989-31-oct-2023.pdf
First published: 31 October 2023
-
Hiv Analyst Call Presentation
Media
https://www.gsk.com/media/8167/hiv-analyst-call-presentation.pdf
First published: 06 June 2022
-
Gold Man Sachs Seminar On Hic And Viiv Healtcare Presentation
Media
https://www.gsk.com/media/8180/gold-man-sachs-seminar-on-hic-and-viiv-healtcare-presentation.pdf
First published: 06 June 2022
-
Jpm 2017 Pv Presentation
Media
https://www.gsk.com/media/8170/jpm-2017-pv-presentation.pdf
First published: 06 June 2022
-
AASLD Press Release
Media
https://www.gsk.com/media/10635/aasld-press-release.pdf
First published: 11 October 2023
-
Fuelling Our Future Growth Slides
Media
https://www.gsk.com/media/8119/fuelling-our-future-growth-slides.pdf
First published: 01 June 2022